As expected, the levels of inflammatory cytokines, and consequently those of MMP-12, were significantly higher in T2DM patients that showed more prominent impairment of CV structure and function than nonT2DM subjects. This evidence concerns the gene MMP12 and type 2 diabetes mellitus.